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A ge-related macular degeneration (AMD) is a leading cause of blindness in industrialized nations. [1] [2] [3] The majority of severe vision loss in AMD is due to the invasion of choroidal blood vessels into the retina, also known as choroidal neovascularization (CNV). The current standard of care for CNV is anti-VEGF-A therapy, which dramatically reduces blindness due to CNV. [4] [5] [6] Still, only about 10% of AMD patients develop CNV; there are no effective therapies for the remaining 90% of AMD patients with the ''dry'' form of disease.
Recently, we reported that multiple nucleoside reverse transcriptase inhibitors (NRTIs), widely used to treat HIV infection, were therapeutic in a mouse model of dry AMD 7 by virtue of their intrinsic anti-inflammatory activity that targeted the purinergic receptor P2X7 and the NLRP3 inflammasome pathway. We also found that one NRTI, stavudine (d4T), suppressed laser-induced CNV in mice in a P2X7-dependent fashion. 7 Interestingly, the P2X7 receptor is known to regulate VEGF-A expression. [8] [9] [10] However, it is not clear whether other NRTIs also block laser-induced CNV via P2X7 or whether they affect VEGF-A in CNV. Furthermore, since P2X7 activity is not necessarily synonymous with NLRP3 inflammasome activation, it is also not clear whether NRTIs influence laser-induced CNV via an NLRP3-dependent or -independent mechanism.
In this present study, we found that three clinically relevant NRTIs (lamivudine [3TC], zidovudine [AZT] , and abacavir sulfate [ABC]) suppressed laser-induced CNV in mice in a P2X7-dependent, NLRP3-independent fashion. Moreover, the P2X7 antagonist A438079 also inhibited laser-induced CNV, and blockade of VEGF-A by NRTIs required P2X7.
MATERIALS AND METHODS

Animals
All animal studies were approved by the University of Kentucky Institutional Animal Care and Use Committee and performed according to their guidelines and the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. C57BL/6J (wild-type) and P2rx7 À/À mice were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). The Nlrp3 À/À mice were obtained from G. Nuñez (University of Michigan). 
Laser-Induced Mouse CNV Model
Laser photocoagulation (532 nm, 180 mW, 100 ms, 75 lm) (OcuLight GL; IRIDEX Corp., Mountain View, CA, USA) was performed bilaterally (volume studies: four spots per eye; protein analyses: 20 spots per eye) in 6-to 8-week-old male mice on day 0 to induce CNV in a masked fashion as previously described. [11] [12] [13] [14] Drug Treatment for CNV The NRTIs 3TC, AZT, and ABC (SelleckChem, Houston, TX, USA) or the P2X7 antagonist A438079 hydrochloride (Tocris, Minneapolis, MN, USA) were dissolved in PBS. For CNV, each group of mice was injected once with 1 lL of NRTIs (3TC, 125 ng/lL; ABC, 183 ng/lL; AZT, 146 ng/lL), 1 lL of A438079 hydrochloride (3, 30, or 300 ng/lL), or the same volume of vehicle (PBS) into the vitreous humor using a 33-gauge needle (Ito Corp., Tokyo, Japan) immediately after laser injury. Another group of mice was injected with 3TC (125 ng) in combination with an anti-mouse VEGF polyclonal antibody (10 ng; R&D Systems, Minneapolis, MN, USA). Goat whole IgG (10 ng; Jackson ImmunoResearch, West Grove, PA, USA) was used as a biological control for the anti-mouse VEGF antibody.
CNV Volume
At 1 week after the laser injury, eyes were enucleated and fixed with 4% paraformaldehyde for 30 minutes at 48C. Eyecups were obtained by removing the anterior segments and were washed in PBS, followed by dehydration and rehydration through a methanol series. After blocking in PBS with 1% bovine serum albumin (Sigma-Aldrich Corp., St. Louis, MO, USA) and 0.5% Triton X-100 (Sigma-Aldrich Corp.) for 1 hour at room temperature, eyecups were incubated with 0.7% FITCisolectin B4 (Vector Laboratories, Burlingame, CA, USA) overnight at 48C. After washing in PBS with 0.1% Triton X-100, the neurosensory retina was gently detached and severed from the optic nerve. Four relaxing radial incisions were made, and the remaining RPE-choroid-sclera complex was flat mounted in antifade medium (Immu-Mount Vectashield Mounting Medium; Vector Laboratories) and coverslipped. Choroidal neovascularization was visualized using a blue argon laser wavelength (488 nm) and a scanning laser confocal micro-scope (TCS SP5; Leica, Heidelberg, Germany), and quantified using Image J software (http://imagej.nih.gov/ij/; provided in the public domain by the National Institutes of Health, Bethesda, MD, USA) in a masked fashion as previously reported. [11] [12] [13] [14] Cell Culture Primary human RPE and HEK293 cells were maintained at 378C in 5% CO 2 and were grown in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal bovine serum, 100 U/mL penicillin, and 100 lg/mL streptomycin (VWR International, Radnor, PA, USA). HEK293 cells with stable expression of human 15 or mouse 16 P2X7 receptors (HEK293-hP2X7 or HEK293-mP2X7) were maintained as above and with G418 disulfate salt (0.4 mg/mL; Sigma-Aldrich Corp.). Primary human RPE cells were isolated as described previously. 7 
VEGF-A ELISA Assay
At 3 days after laser injury, the RPE-choroid complex was sonicated in radioimmunoprecipitation assay (RIPA) buffer (Sigma-Aldrich Corp.) with protease inhibitor (Sigma-Aldrich Corp.) on ice for 15 minutes. The lysate was centrifuged at 20,000g for 15 minutes at 48C, and the VEGF protein levels in the supernatants were measured by enzyme-linked immunosorbent assay (ELISA) for mouse VEGF-A (Quantikine Immunoassay, R&D Systems) as described by the manufacturer. Total protein of the lysates was quantified by bicinchoninic acid (BCA) assay.
HEK293 or HEK293-hP2X7 cells (5 3 10 5 ) were plated into six-well plates in complete medium and allowed to adhere for 24 hours. Cells were then incubated for 24 more hours in the absence or presence of 150 lM 2 0 ,3 0 -(benzoyl-4-benzoyl)-ATP (Bz-ATP). Cells incubated in the presence of Bz-ATP were also incubated with or without 3TC (100 lM), which was added 30 minutes before Bz-ATP. VEGF release into the supernatants was measured by ELISA for human VEGF-A (Quantikine Immunoassay, R&D Systems) as described by the manufacturer.
Real-Time Quantitative PCR
Primary human RPE cells were plated into 12-well plates in complete medium and allowed to adhere for 24 hours. Cells were then incubated for 2 hours in the absence or presence of Bz-ATP (150 lM). Cells incubated in the presence of Bz-ATP were also incubated with or without 3TC (100 lM), which was added 30 minutes before Bz-ATP. Total RNA was collected in reagent (Trizol; Invitrogen, Carlsbad, CA, USA) and reverse transcribed with a reverse transcription kit (QuantiTect; Qiagen, Valencia, CA, USA). The cDNA was amplified by quantitative real-time PCR (qPCR) (7900 HT Fast Real-Time PCR; Applied Biosystems, Foster City, CA, USA) with Power SYBR Green Master Mix (Invitrogen). Oligonucleotide primers specific for human VEGFA (F 5 0 AAGGAGGAGGGCAGAATCAT 3 0 ; R 5 0 GCAGTAGCTGCGCTGATAGA 3 0 ) and IL6 (F 5 0 CTCCTTCTCCACAAGCGCCTTC 3 0 ; R 5 0 GCGCAGAATGAGAT GAGTTGTC 3 0 ) mRNA were used and normalized to 18S (F 5 0 CGCAGCTAGGAATAATGGAATAGG; R 5 0 GCCTCAGTTCCG AAAACCAA 3 0 ). The qPCR cycling conditions were 508C for 2 minutes, 958C for 10 minutes, followed by 40 cycles of a twostep amplification program (958C for 15 seconds and 588C for 1 minute). Relative expression of target genes was determined by the 2 ÀDD Ct method.
Statistical Analysis
All results were expressed as mean plus or minus standard error of the mean (n ¼ number of eyes) with P < 0.05 considered statistically significant as determined by one-way ANOVA with Dunn, Student-Newman-Keuls, or Tukey post hoc tests, as appropriate.
RESULTS
NRTIs Supressed Laser-Induced CNV in a P2X7-Dependent, NLRP3-Independent Fashion
Intravitrous injection of the NRTIs 3TC, AZT, or ABC suppressed the laser-induced CNV in wild-type mice compared to PBS vehicle (Fig. 1) . On the other hand, intravitreous injection of 3TC, AZT, or ABC did not suppress the laserinduced CNV in P2rx7 À/À mice (Fig. 2) . Also supporting the involvement of P2X7 in laser-induced CNV was our finding that the selective P2X7 antagonist A438079 suppressed laserinduced CNV (Fig. 3) . Nlrp3 was not required for the antiangiogenic effect of NRTIs, as intravitreous injection of 3TC, AZT, or ABC suppressed laser-induced CNV in Nlrp3 À/À mice (Fig. 4 ).
NRTIs Suppressed VEGF-A Levels in a P2X7-Dependent Fashion
The mean level of VEGF-A in the RPE/choroid, which peaks on day 3 after laser injury, 17 was significantly reduced in 3TC-, AZT-and ABC-treated eyes compared with control eyes in wildtype mice, but not in P2rx7 À/À mice (Fig. 5 ). Intravitreous injection of an anti-mouse VEGF-A antibody reduced laserinduced CNV in wild-type mice compared with a control IgG; in support of the idea that the antiangiogenic effect of NRTIs is achieved by VEGF-A inhibition, 3TC did not suppress CNV when coadministered with this VEGF-A neutralizing antibody (Fig. 6) .
To further test the effect of NRTIs on VEGF-A via P2X7, we utilized HEK293 cells stably expressing the human or mouse P2X7 receptors (HEK293-hP2X7/HEK293-mP2X7). The selective P2X7 agonist Bz-ATP increased VEGF-A secretion into the cell culture media from both HEK293-hP2X7 and HEK293- mP2X7 cells compared to control-treated cells, an effect that was diminished upon 3TC treatment (Fig. 7) .
Finally, we explored whether 3TC affected Bz-ATP-induced angiogenic cytokine expression in primary human RPE cells, which are known to produce VEGF-A and IL-6. 18, 19 We found that 3TC blocked Bz-ATP-induced VEGFA and IL6 mRNA expression ( Fig. 8 ). Like VEGFA, IL6 is proangiogenic, regulated by P2X7, 20 and known to be involved in laser CNV. [21] [22] [23] This result suggests that NRTIs could modulate angiogenesis by affecting the expression of multiple P2X7dependent cytokines in RPE cells.
DISCUSSION
The repurposing of NRTIs is currently being pursued as a therapeutic strategy for the treatment of dry AMD. Since CNV often coexists on a background of dry AMD in humans, it is prudent to also evaluate the effect of NRTIs on CNV. The first distinct role for P2X7 in modulating CNV was recently reported. 7 Another study showed that a nonselective P2 receptor antagonist reduced laser CNV in mice, although the role of P2X7 per se was not clear. 24 Here we found that multiple clinically relevant NRTIs blocked laser-induced CNV in mice and that P2X7 was required for their antiangiogenic function (Fig. 1, 2) . The selective P2X7 antagonist A438079 also inhibited laser-induced CNV in mice (Fig. 3) .
There is precedent for the proangiogenic function of P2X7 in experimental cancer systems. P2X7-overexpresing HEK293 and CT26 cells form solid tumors that show an accelerated in vivo growth rate, higher VEGF-A release, and thicker vascular network in mice relative to hypo-expressing P2X7 parental cells. The in vivo growth rate of P2X7-expressing tumors was blunted by VEGF-A neutralization; moreover, P2X7 inhibition blocked tumor growth and reduced VEGF-A levels in this system, 9 in line with previous reports indicating that P2X7 regulates VEGF-A expression and secretion in various cell types. 8, 10, 25 Our data are consistent with the idea that the angio-inhibitory effects of NRTIs are mediated by P2X7 inhibition and VEGF-A suppression ( Fig. 5-7) .
Future work should clarify the identity of the P2X7expressing cell type(s) that mediate the antiangiogenic effects of NRTIs in laser-induced CNV. Mouse RPE cells in vivo express P2X7, as do mouse RPE primary cell cultures. 26 It is also known that RPE cells are a dominant source of VEGF production in the murine retina. 27, 28 Therefore, it is tempting to speculate that NRTIs modulate angiogenesis by acting directly on RPE cells to control VEGF-A levels. Primary and immortalized (ARPE-19) human RPE cells also express functional P2X7 in cell culture. 26 On the other hand, monocytes and macrophages, which express high levels of P2X7, 29 are recruited to the choroid after laser injury and drive angiogenesis via VEGF production. 17, 30, 31 Thus, future work will be required to determine whether NRTIs block local VEGF-A release by infiltrating macrophages or by RPE cells. P2X7 [32] [33] [34] and VEGF-A 35, 36 are also involved in regulating immune cell chemotaxis. In contrast to VEGF-A, the proposed chemotactic role of P2X7 in the laser-induced mouse model of CNV is not clear. For these reasons, we speculate that NRTIs could modulate laser-induced CNV by modulating monocyte/macrophage migration.
Nucleoside reverse transcriptase inhibitors could also reduce laser-induced CNV via other P2X7-dependent molecules ( Fig. 8) . Besides VEGF-A, P2X7 is known to regulate the expression of other proangiogenic cytokines that modulate laser-induced CNV, including IL-6 [21] [22] [23] and TNF-a 37, 38 ; these cytokines have also been reported in human CNV membranes 39 and in the aqueous humor 40 of CNV patients. Nucleoside reverse transcriptase inhibitors blocked plasma IL-6 and TNF-a levels in a mouse model of graft-versus-host disease 7 ; future work will be required to determine whether NRTIs also inhibit these cytokines in CNV. P2X7 is also known to regulate the expression of the chemotactic ligand MCP-1/ CCL2, 22, 41 which is known to be involved in neovascularization and immune cell migration. [42] [43] [44] Interestingly, the CNV lesion size of P2rx7 À/À mice is similar to that of wild-type mice (Figs. 1, 2) , despite having reduced VEGF-A levels (Fig. 5) , which is consistent with the idea that VEGF-A is not the only angiogenic cytokine that modulates laser CNV.
P2X7 is also a critical signaling intermediate in NLRP3 inflammasome activation. Although NRTIs block P2X7-dependent NLRP3 inflammasome activation, 7, 45 our data indicate that Nlrp3 is not required for NRTI-induced CNV suppression (Fig.  4 ). NLRP3 expression is increased in histologic sections of human CNV specimens. 46 However, the role of the NLRP3 inflammasome in modulating CNV remains contentious. One group has reported that genetic inhibition of NLRP3 47 reduces laser-induced CNV. On the other hand, a consortium of five research groups could not reproduce the earlier group's findings. 48 Regardless of these differences, the data presented here indicate that NRTIs block P2X7-dependent NLRP3independent laser-induced CNV.
Previous work indicated that d4T blocked laser-induced CNV independent of reverse transcriptase inhibition since its methoxy-modified variant also inhibited P2X7-dependent laserinduced CNV. 7 In the future, the creation of methoxy-modified NRTIs for 3TC, ABC, and AZT would support the idea that these NRTIs also reduce laser-induced CNV independent of reverse transcriptase inhibition.
